|Evotec AG -- USA Stock|| |
USD 20.35 0.00 0.00%
Deputy Chairman of the Supervisory Board
Mr. Roland Oetker was appointed as Deputy Chairman of the Supervisory Board of Evotec AG as of June 12 2013. Prior to that he was Member of the Supervisory Board of Evotec AG since June 16 2011. He is the Founder and Managing Director of ROI Verwaltungsgesellschaft mbH. He also serves as Honorary President of Deutsche Schutzvereinigung fuer Wertpapierbesitz e.V. Starting out as a lawyer in 1983. Mr. Oetker worked with the Deutsche Bank AG and was a CoChairman of the Managing Board of Massa AG. He was Member of the Supervisory Board of Deutsche Post AG since 2004 and of RheinischBergische Verlagsgesellschaft mbH since 2011
Age: 64 Chairman Since 2013
49 40 5 60 81 0 http://www.evotec.com
Oetker was Member of the Board of Trustees of the RAG foundation since 2007. He had his professional training with Sal. Oppenheim jr. & Cie., Koeln, Schroder Banking Corporationrationration, New York and Lauter, Fischer & Partner, Koeln. Following his studies of economics and law in Saarbruecken and Muenster and passing his German bar exams he became a lawyer.
The company has return on total asset (ROA)
of 4.56 %
which means that it generated profit of $4.56 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 11.13 %
meaning that it generated $11.13 on every $100 dollars invested by stockholders.
The company has accumulated 213.13 M in total debt with debt to equity ratio (D/E) of 53.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Evotec AG has Current Ratio of 0.68 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Evotec AG provides drug discovery solutions to the pharmaceutical and biotechnology companies, academic institutions, and foundations and not-for-profit organizations worldwide. Evotec AG was founded in 1993 and is headquartered in Hamburg, Germany. Evotec AG is traded on OTC Market in USA.Evotec AG (EVOTF) is traded on OTC Market in USA. It is located in Manfred Eigen Campus and employs 1,238 people.